NCT03401450

Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 69 (actual)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, randomized, single blinded trial involving human subjects. The goal of this study is to determine an optimal location (proximal or distal) for the nerve block and whether it will make a difference in how much opioid the patient will receive during and after surgery. Ultrasound will identify the adductor canal and the proximal end of the adductor canal/apex of the femoral triangle to determine the location of the blocks. Their will be two randomized groups: 1. ACB within true AC with bupivacaine 0.5% 20cc2. ACB proximal to true AC with bupivacaine 0.5% 20cc

Conditions

• ACL Surgery

Interventions

Type	Name	Description
DRUG	ACB within true AC with bupivacaine 0.5% 20cc	The adductor canal block (ACB) is more commonly being used to provide post-operative analgesia since it provides a sensory block with minimal motor block.
DRUG	ACB proximal to true AC with bupivacaine 0.5% 20cc	Patients will receive ultra-sound guided single femoral triangle block injection with 20 mL of 0.5% bupivicaine

Timeline

• Start date: 2018-02-01
• Primary completion: 2019-01-25
• Completion: 2021-06-29
• First posted: 2018-01-17
• Last updated: 2023-07-14
• Results posted: 2020-12-23

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study